AI Detects Cancer Metastases

  • Author: ChemistryViews.org
  • Published: 24 December 2019
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
  • Source / Publisher: Cell/Elsevier Inc.
thumbnail image: AI Detects Cancer Metastases

More than 90 % of cancer patients do not die from the consequences of the primary tumor but the metastases. How and why certain tumors spread and others do not, and how the metastases spread in different types of cancer, is still only partially known.

Ali Ertürk, Helmholtz Zentrum München, Germany, and colleagues have developed a method to detect even the smallest metastases down to individual cancer cells in experimental mice. First, the scientists use tissue clearing to make the mouse tissue transparent. They then scan the entire body with a laser scanning microscope.

Second, they developed a deep learning algorithm, named DeepMACT. It automatically detects and analyzes cancer metastases and maps the distribution of therapeutic antibodies. The DeepMACT detects the metastases with an accuracy comparable to that of a human expert, but it is more than 300 times faster.

According to the researchers, DeepMACT is the first method that allows a quantitative analysis of the metastatic process on a full-body scale. Scientists now have a tool with which they can assess the effectiveness of clinical cancer therapies using tumor-specific monoclonal antibodies.

As a representative example, the team used DeepMACT to quantify the effectiveness of the therapeutic antibody 6A10, which has been shown to reduce tumor growth. However, the new results showed that this antibody can miss up to 23 % of the metastases in the bodies of the affected mice.


 

 

 

Article Views: 1448

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)published by Wiley-VCH